Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-19-074077
Filing Date
2019-12-19
Accepted
2019-12-19 08:02:37
Documents
2
Period of Report
2019-12-17

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 19001
2 EX-24 ex-24.htm EX-24 9328
  Complete submission text file 0001104659-19-074077.txt   29711
Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971
CATABASIS PHARMACEUTICALS INC (Issuer) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 100 HIGH STREET 28TH FLOOR BOSTON MA 02110
Business Address
Clauser Noah (Reporting) CIK: 0001796466 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37467 | Film No.: 191294167